Sumitomo Pharma Co., Ltd. (TSE:4506) agreed to acquire MELTz Business of MELTIN MMI Co., Ltd. on April 16, 2024.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
332 JPY | -4.87% | +16.08% | -28.76% |
14/05 | Transcript : Sumitomo Pharma Co., Ltd., 2024 Earnings Call, May 14, 2024 | |
14/05 | Sumitomo Pharma Co., Ltd. Provides Consolidated Earnings Guidance for the Year Ending March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-28.76% | 89Cr | |
+42.69% | 75TCr | |
+37.90% | 61TCr | |
-6.87% | 35TCr | |
+18.74% | 33TCr | |
+6.76% | 29TCr | |
+18.30% | 25TCr | |
-3.39% | 21TCr | |
+10.86% | 22TCr | |
+2.64% | 17TCr |
- Stock Market
- Equities
- 4506 Stock
- News Sumitomo Pharma Co., Ltd.
- Sumitomo Pharma Co., Ltd. agreed to acquire MELTz Business of MELTIN MMI Co., Ltd.